mjn-neuro is a company dedicated to the design, manufacture and commercialization of medical devices with the aim of improving people's quality of life. All this activity is accompanied by an important policy of reinvestment of resources in R&I and social action.
The first device that mjn-neuro is developing is mjn-SERAS: an earpiece that assesses the risk of epileptic seizures. The product consists of the earpiece and an app, which are connected to each other via Bluetooth. The earpiece is customised for each user. The main function of the earpiece is to send a warning when the risk of epileptic seizures is high. This signal is both, visual and acoustic, and alerts each user between 1 and 3 minutes before having a seizure.
Company Details
Mjn-Neuro Questions
Mjn-Neuro's helpline number is 34652918809
Mjn-Neuro's website is mjn.cat
Mjn-Neuro's LinkedIn profile is https://es.linkedin.com/company/mjn-neuro
Mjn-Neuro has
23 employees.
View email and phone details for 23
employees at Mjn-Neuro.
Mjn-Neuro's industry is
Biotechnology Research
Mjn-Neuro's top competitors are
Biome Diagnostics,
Aptadel Therapeutics,
Cellectric Biosciences,
Nimbio,
The Blue Box Biomedical Solutions,
Fusix Biotech Gmbh,
Rejuversen,
Tucuvi,
Nimble Diagnostics,
Corify.
Mjn-Neuro's support email address is Info@mjnseras.com
Mjn-Neuro's categories are Biotechnology Research
Mjn-Neuro's founding year is 2014
